-transparent.png){kind=logo}
D-penicillamine is one of the disease-modifying anti-rheumatic drugs (DMARDs). Drug-induced pemphigus is not fre-quently associated with D-penicillamine, and to date, the number of reported cases is about a hundred. Most reports of D-penicillamine-induced pemphigus vulgaris are in patients with rheumatoid arthritis. It has rarely been reported in patients not taking D-penicillamine. We report a case of pemphigus vulgaris in a 48-year-old female patient with rheumatoid arthri-tis, not taking penicillamine.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Narges Gholizadeh, and
Ali Taghavi Zenouz, and
Hossein Eslami
January 2007,
Skinmed,
Narges Gholizadeh, and
Ali Taghavi Zenouz, and
Hossein Eslami
January 2004,
Acta dermato-venereologica,
Narges Gholizadeh, and
Ali Taghavi Zenouz, and
Hossein Eslami
May 1988,
Clinical nephrology,
Narges Gholizadeh, and
Ali Taghavi Zenouz, and
Hossein Eslami
January 1981,
Scandinavian journal of rheumatology,
Narges Gholizadeh, and
Ali Taghavi Zenouz, and
Hossein Eslami
January 1982,
The Journal of rheumatology,
Narges Gholizadeh, and
Ali Taghavi Zenouz, and
Hossein Eslami
November 1978,
Die Medizinische Welt,
Narges Gholizadeh, and
Ali Taghavi Zenouz, and
Hossein Eslami
February 1983,
Harefuah,
Narges Gholizadeh, and
Ali Taghavi Zenouz, and
Hossein Eslami
September 1983,
The New England journal of medicine,
Narges Gholizadeh, and
Ali Taghavi Zenouz, and
Hossein Eslami
June 1984,
Journal of clinical neuro-ophthalmology,
Narges Gholizadeh, and
Ali Taghavi Zenouz, and
Hossein Eslami
January 1984,
Scandinavian journal of rheumatology,
